Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2011
03/03/2011WO2011025006A1 Gpr119 agonist
03/03/2011WO2011024987A1 Aromatic fused heterocyclic derivative and pharmaceutical composition containing same
03/03/2011WO2011024933A1 3-(biaryloxy) propionic acid derivative
03/03/2011WO2011024192A2 Novel polymorphs of raltegravir
03/03/2011WO2011024001A1 Np-1 antagonists and their therapeutic use
03/03/2011WO2011023795A1 (thio)morpholine derivatives as s1p modulators
03/03/2011WO2011023753A1 Benzoxazine derivatives as glycine transport inhibitors
03/03/2011WO2011023703A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
03/03/2011WO2011023626A1 Pyrrolidine derivatives as nk3 receptor antagonists
03/03/2011WO2010046931A3 Antifungal compounds containing benzothiazinone, benzoxazinone or benzoxazolinone and process thereof
03/03/2011WO2008078200A3 Benzenesulfonamide derivatives as hiv protease inhibitors
03/03/2011WO2008035209A3 Quinoline and quinazoline derivatives as inhibitors of protein tyrosine kinase activity
03/03/2011US20110054176 Quinoline-oxazoline compounds and their use in oxidation synthesis
03/03/2011US20110053993 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents
03/03/2011US20110053982 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
03/03/2011US20110053954 Method of treatment and/or prevention of brain, spinal or nerve injury
03/03/2011US20110053950 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
03/03/2011US20110053948 Pyrrolidines as nk3 receptor antagonists
03/03/2011US20110053943 CARBAMATE AND UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1
03/03/2011US20110053941 IDO Inhibitors
03/03/2011US20110053940 3,4-substituted piperidine derivatives as renin inhibitors
03/03/2011US20110053939 Novel aromatic nitro compounds
03/03/2011US20110053938 Compounds and Compositions For Treating Cancer
03/03/2011US20110053937 Inhibitors of the Interaction Between MDM2 and P53
03/03/2011US20110053936 substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
03/03/2011US20110053935 Fused pyridines active as inhibitors of c-met
03/03/2011US20110053934 Compounds and methods of treatment
03/03/2011US20110053933 Hydroxyquinoxalinecarboxamide derivative
03/03/2011US20110053932 Protein Kinase Inhibitors and Methods for Using Thereof
03/03/2011US20110053931 Quinoline compounds and methods of use
03/03/2011US20110053925 Hydroxamate-Based Inhibitors of Deacetylases
03/03/2011US20110053924 Substituted piperidines as renin inhibitors
03/03/2011US20110053923 Chemical compounds 610
03/03/2011US20110053920 Substituted bicyclic pyrimidines
03/03/2011US20110053918 Gamma secretase modulators
03/03/2011US20110053916 Pyrimidine compounds as tuberculosis inhibitors
03/03/2011US20110053912 Pyrimidine compound
03/03/2011US20110053907 Substituted pyrimidines and triazines and their use in cancer therapy
03/03/2011US20110053905 Compounds as tyrosine kinase modulators
03/03/2011US20110053891 5-fluoropyrimidinone derivatives
03/03/2011US20110053848 Prodrug comprising a drug linker conjugate
03/03/2011US20110052562 Benzimidazoles and analogs as rho kinase inhibitors
03/03/2011US20110049445 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same
03/03/2011CA2772575A1 Raf inhibitor compounds and methods of use thereof
03/03/2011CA2772169A1 (thio)morpholine derivatives as s1p modulators
03/03/2011CA2772164A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
03/03/2011CA2772093A1 Np-1 antagonists and their therapeutic use
03/03/2011CA2771601A1 Morpholinone compounds as factor ixa inhibitors
03/03/2011CA2770475A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
03/03/2011CA2767770A1 Pyrrolidine derivatives as nk3 receptor antagonists
03/02/2011EP2289890A1 Compounds for the treatment of multi-drug resistant bacterial infections
03/02/2011EP2289883A1 Novel FXR (NR1H4) binding and activity modulating compounds
03/02/2011EP2289877A1 Organic light emitting device containing polycyclic heteroaryl compounds
03/02/2011EP2288607A1 Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
03/02/2011EP2288606A1 New co-crystal compound of rivaroxaban and malonic acid
03/02/2011EP2288605A1 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
03/02/2011EP2288604A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
03/02/2011EP2288602A1 Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
03/02/2011EP2288601A1 Bicyclylaryl-aryl-amine compounds and their use
03/02/2011EP2288594A1 Imidazolidine derivatives
03/02/2011EP2137181B1 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
03/02/2011EP2035417B1 Benzimidazoles and their use for the treatemnt of diabetes
03/02/2011EP2004601B1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
03/02/2011EP1901731B1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
03/02/2011EP1831174B1 Amide derivatives
03/02/2011EP1585737B1 Uracils having a herbicidal activity
03/02/2011EP1581518B1 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
03/02/2011CN101983197A A novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
03/02/2011CN101982468A Novel oxazolidinone derivatives and pharmaceutical compositions comprising the derivatives
03/02/2011CN101193869B Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/01/2011US7897783 Intermediate compound for synthesis of viridiofungin a derivative
03/01/2011US7897765 Therapeutic compounds and uses thereof
03/01/2011US7897761 Heterocyclic compound
03/01/2011US7897635 HIV protease inhibitors
03/01/2011US7897634 Pyrazoles for the treatment of obesity and other CNS disorders
03/01/2011US7897630 5-aryl isoxazolines for controlling invertebrate pests
03/01/2011US7897627 Heteroaryl derivatives as orexin receptor antagonists
03/01/2011US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists
03/01/2011US7897602 Indolinone compounds as kinase inhibitors
03/01/2011US7897600 Amino pyrazole compound
03/01/2011US7897597 Aryloxy and arylalkyleneoxy substituted imidazoquinolines
03/01/2011CA2602348C Cyclopentapyridine and tetrahydroquinoline derivatives
03/01/2011CA2468529C 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
02/2011
02/24/2011WO2011022473A1 Biaryl compounds and methods of use thereof
02/24/2011WO2011022348A1 Ethylene diamine modulators of fatty acid amide hydrolase
02/24/2011WO2011021726A2 Nitrogen-containing compound and pharmaceutical composition
02/24/2011WO2011021209A1 Histone deacetylase inhibitors
02/24/2011WO2011020806A1 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives
02/24/2011WO2011020615A1 Novel fxr (nr1h4 ) binding and activity modulating compounds
02/24/2011WO2010121164A3 1,4-benzodiazepinone compounds and their use in treating cancer
02/24/2011WO2010108052A3 Amide derivatives as neuropeptide y5 receptor ligands
02/24/2011US20110046370 1,3,6-substituted indole derivatives having inhibitory activity for protein kinase
02/24/2011US20110046170 Novel pyrimidine-pyridine derivatives
02/24/2011US20110046162 Fused cyanopyridines and the use thereof
02/24/2011US20110046158 Capped pyrazinoylguanidine sodium channel blockers
02/24/2011US20110046137 Pyrazole Derivatives as P2X7 Modulators
02/24/2011US20110046135 New compounds i
02/24/2011US20110046133 Organic compounds
02/24/2011US20110046132 Benzoimidazoles as prolyl hydroxylase inhibitors
02/24/2011US20110046129 2-Phenylethylamino Derivatives as Calcium and/or Sodium Channel Modulators